Investing in Anti-Aging Biotech Stocks
Perry Gardner was 81 when he died.
A former postal worker, Perry, and his wife moved to Florida after they retired.
They had a beautiful home, a sizable nest egg, and the life they had always looked forward to.
Unfortunately, Perry wasn’t in the best shape.
You see, about 10 years ago, Perry’s knees started to give out.
After years of wear and tear from walking his mail route, carrying multiple bags of mail up and down the sidewalks of Waltham, Massachusetts, he developed osteoarthritis. It got so bad that for the past couple of years, he could barely walk, and spent most of his time in a wheelchair.
The doctors say his lack of exercise and movement contributed to a weakened immune system, which left him susceptible to catching the coronavirus. And that’s exactly what happened.
What’s most frustrating about this, however, is that had Perry been able to exercise and stay healthy, his body would’ve likely been able to battle the virus along with dozens of other sicknesses that tend to attack those with compromised immune systems.
While there are a lot of companies racing to find a cure for this virus, the reality is that there will be more. Maybe a different strain of this virus, or perhaps something entirely different. And although it’s difficult to find cures for these things, there’s one thing we know that can help protect people from getting sick: a strong immune system.
And the only way to build a strong immune system is to eat clean, healthy food, and exercise.
But what if there were another way?
The End of Aging
It may sound like something out of a science fiction movie, but there’s a company that’s right now working on a special kind of treatment that would make it possible for us to successfully win the battle against age-related diseases.
Essentially, making it possible for our bodies to remain strong and healthy, even as we live well into our 80s, 90s, and beyond.
Such a thing does exist, and the company leading the way on this research is public. You can actually buy shares of it right now.
I’ll tell you more about that in a moment, but first, let me explain what happens to our bodies as we get older, and how this company’s technology could slow this process.
You see, throughout one’s life, cells divide until they encounter some form of biologic stress, at which point they pull a form of cellular emergency brake causing them to cease dividing — forever.
This results in an accumulation of a certain kind of cells that secrete large quantities of harmful proteins, which cause inflammation, tissue degradation, and the production of growth factors that alter the tissue microenvironment. This is what scientists now believe leads to several age-associated diseases.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
I first learned about this in an issue of the MIT Technology Review.
The research was fascinating, so I decided to do some investigating to see who was leading this research, and which companies were working with the FDA on clinical trials.
I found one, and it currently has five different aging-related treatments in its pipeline. One of which is now in Phase 2 trials, with results expected in less than two months. If those results come back positive, this company will likely get scooped up by a major pharmaceutical company. And those who own shares of it before then could walk away with life-changing gains.
How big are we talking, here?
Well, according to The Longevity Fund, a venture capital firm that invests specifically in anti-aging related companies, a single age-related indication could be worth a couple hundred billion dollars. That’s billion, with a “B.”
And don’t forget, this company has five different aging-related treatments in its pipeline.
I wrote a report, detailing those five treatments, along with more about this company, its competitors, and the science of anti-aging medicine. You can download it for free here.
While this company’s new therapy wasn’t ready in time for Perry Gardner to get it, it could soon be available for others. And just imagine how amazing that would be.
Think about the millions of people suffering from all kinds of age-related diseases that could be cured, or at least live much fuller and healthier lives.
Make no mistake: This is the very definition of ground-breaking. And rest assured, the profits from such a thing could be life-changing. And that’s why I encourage you to read more about this company and the anti-aging treatments it's developing here.
To a new way of life and a new generation of wealth...
@JeffSiegel on Twitter
Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.
Energy Demand will Increase 58% Over the Next 25 Years
After getting your report, you’ll begin receiving the Energy and Capital e-Letter, delivered to your inbox daily.